USANA Health Sciences Inc (USNA)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 76,321 92,533 94,456 101,063 102,453 98,644 101,337 103,835 108,621 117,465 134,591 159,593 170,642 193,527 197,452 183,121 177,948 169,219 160,832 153,365
Revenue (ttm) US$ in thousands 856,402 864,228 877,532 902,933 923,927 930,694 950,819 977,178 1,001,860 1,041,382 1,082,496 1,155,009 1,190,168 1,235,586 1,258,823 1,180,028 1,137,751 1,095,421 1,057,506 1,054,531
Pretax margin 8.91% 10.71% 10.76% 11.19% 11.09% 10.60% 10.66% 10.63% 10.84% 11.28% 12.43% 13.82% 14.34% 15.66% 15.69% 15.52% 15.64% 15.45% 15.21% 14.54%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $76,321K ÷ $856,402K
= 8.91%

The pretax margin of USANA Health Sciences Inc has shown a gradual decline over the past few years based on the provided data. The pretax margin decreased from 14.54% in March 2020 to 8.91% by December 2024. This indicates that the company's profitability before taxes has been reducing over time.

The trend highlights potential challenges in managing costs, generating revenue, or both, which could be impacting the company's overall financial performance. It is important for USANA Health Sciences Inc to closely monitor and address the factors contributing to this decline in pretax margin to sustain its financial health and profitability in the long term.